2019 Premature Ejaculation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Premature Ejaculation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Premature Ejaculation. It presents in-depth analysis of Premature Ejaculation clinical trials across markets and companies. The research work is for providing complete understanding into trends in Premature Ejaculation.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Premature Ejaculation clinical trials by-
The research work is prepared through extensive and continuous research on Premature Ejaculation trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Premature Ejaculation clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Premature Ejaculation trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Premature Ejaculation patients are identified
- The report includes panorama of Premature Ejaculation clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Premature Ejaculation clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Premature Ejaculation Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Premature Ejaculation Clinical Trials by Region
2.2.2 Average Enrollment of Premature Ejaculation Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Premature Ejaculation Treatment, 2019
3. REGION WISE PREMATURE EJACULATION CLINICAL TRIALS
3.1 Asia Pacific Premature Ejaculation Clinical Trials by Country
3.2 Europe Premature Ejaculation Clinical Trials by Country
3.3 North America Premature Ejaculation Clinical Trials by Country
3.4 Middle East and Africa Premature Ejaculation Clinical Trials by Country
3.5 South and Central America Premature Ejaculation Clinical Trials by Country
4. PREMATURE EJACULATION CLINICAL TRIAL TRENDS
4.1 Start Year wise Premature Ejaculation Clinical Trials
4.2 Phase wise Premature Ejaculation Clinical Trials
4.3 Trial Status wise Premature Ejaculation Clinical Trials
4.4 Trial Type wise Premature Ejaculation Clinical Trials
5. PREMATURE EJACULATION AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Premature Ejaculation Trials by Year
5.2 Average Enrollment in Premature Ejaculation Trials by Phase
5.3 Average Enrollment in Premature Ejaculation Trials by Status
5.4 Average Enrollment in Premature Ejaculation Trials by Type of Trial
6. COMPANIES PARTICIPATING IN PREMATURE EJACULATION CLINICAL TRIALS
6.1 Premature Ejaculation Trials by Sponsor Type
6.2 Premature Ejaculation Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Premature Ejaculation Trials- Phase
7.2 Premature Ejaculation Trials- Phase
7.3 Premature Ejaculation Trials- Phase
7.4 Premature Ejaculation Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Premature Ejaculation Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Premature Ejaculation Clinical Trials by Region
2.2.2 Average Enrollment of Premature Ejaculation Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Premature Ejaculation Treatment, 2019
3. REGION WISE PREMATURE EJACULATION CLINICAL TRIALS
3.1 Asia Pacific Premature Ejaculation Clinical Trials by Country
3.2 Europe Premature Ejaculation Clinical Trials by Country
3.3 North America Premature Ejaculation Clinical Trials by Country
3.4 Middle East and Africa Premature Ejaculation Clinical Trials by Country
3.5 South and Central America Premature Ejaculation Clinical Trials by Country
4. PREMATURE EJACULATION CLINICAL TRIAL TRENDS
4.1 Start Year wise Premature Ejaculation Clinical Trials
4.2 Phase wise Premature Ejaculation Clinical Trials
4.3 Trial Status wise Premature Ejaculation Clinical Trials
4.4 Trial Type wise Premature Ejaculation Clinical Trials
5. PREMATURE EJACULATION AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Premature Ejaculation Trials by Year
5.2 Average Enrollment in Premature Ejaculation Trials by Phase
5.3 Average Enrollment in Premature Ejaculation Trials by Status
5.4 Average Enrollment in Premature Ejaculation Trials by Type of Trial
6. COMPANIES PARTICIPATING IN PREMATURE EJACULATION CLINICAL TRIALS
6.1 Premature Ejaculation Trials by Sponsor Type
6.2 Premature Ejaculation Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Premature Ejaculation Trials- Phase
7.2 Premature Ejaculation Trials- Phase
7.3 Premature Ejaculation Trials- Phase
7.4 Premature Ejaculation Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Premature Ejaculation Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 5: Europe – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 7: North America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 9: Premature Ejaculation Clinical Trials by Phase
Figure 10: Premature Ejaculation Clinical Trials by Trial Status
Figure 11: Premature Ejaculation Clinical Trials by Type
Figure 12: Premature Ejaculation Clinical Trials by Sponsor Type
Figure 13: Premature Ejaculation Clinical Trials by Leading Sponsors
Figure 14: Premature Ejaculation Average Enrollment by Phase
Figure 15: Premature Ejaculation Average Enrollment by Trial Status
Figure 16: Premature Ejaculation Average Enrollment by Type
Figure 17: Premature Ejaculation- Average Enrolment by Type of Sponsors
Figure 18: Premature Ejaculation- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Premature Ejaculation Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 5: Europe – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 7: North America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Figure 9: Premature Ejaculation Clinical Trials by Phase
Figure 10: Premature Ejaculation Clinical Trials by Trial Status
Figure 11: Premature Ejaculation Clinical Trials by Type
Figure 12: Premature Ejaculation Clinical Trials by Sponsor Type
Figure 13: Premature Ejaculation Clinical Trials by Leading Sponsors
Figure 14: Premature Ejaculation Average Enrollment by Phase
Figure 15: Premature Ejaculation Average Enrollment by Trial Status
Figure 16: Premature Ejaculation Average Enrollment by Type
Figure 17: Premature Ejaculation- Average Enrolment by Type of Sponsors
Figure 18: Premature Ejaculation- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Premature Ejaculation Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 5: Europe – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 7: North America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Premature Ejaculation Average Enrollment by Phase
Table 15: Premature Ejaculation Average Enrollment by Trial Status
Table 16: Premature Ejaculation Average Enrollment by Type
Table 17: Premature Ejaculation- Average Enrolment by Type of Sponsors
Table 18: Premature Ejaculation- Enrolment by Leading Sponsors
Table 1: Premature Ejaculation Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 5: Europe – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 7: North America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Premature Ejaculation Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Premature Ejaculation Average Enrollment by Phase
Table 15: Premature Ejaculation Average Enrollment by Trial Status
Table 16: Premature Ejaculation Average Enrollment by Type
Table 17: Premature Ejaculation- Average Enrolment by Type of Sponsors
Table 18: Premature Ejaculation- Enrolment by Leading Sponsors
